ASSESSMENT OF GLYCEMIC PARAMETERS IN DIABETIC PATIENTS
DOI:
https://doi.org/10.63330/armv2n4-004Keywords:
Diabetes mellitus, Glycemic control, Glycated hemoglobin, Fasting blood glucose, Metabolic monitoringAbstract
Diabetes mellitus is one of the most prevalent chronic diseases in contemporary public health, characterized by persistent alterations in glucose metabolism and the potential to trigger various systemic complications over time. In this context, adequate monitoring of glycemic parameters becomes essential for metabolic control and the prevention of progressive damage associated with the disease. This study aimed to analyze the main glycemic parameters used in the monitoring of diabetic patients, highlighting their importance in blood glucose monitoring and the prevention of chronic complications. The research was developed through a descriptive literature review with a qualitative approach, conducted in recognized scientific databases, analyzing studies published between 2020 and 2025. The investigation identified that tests such as fasting blood glucose and glycated hemoglobin represent fundamental tools for assessing glycemic control, contributing to clinical monitoring and guiding therapeutic strategies. It was also observed that behavioral factors, such as diet, physical activity, and adherence to medication treatment, exert a significant influence on glycemic levels. It is concluded that regular assessment of glycemic parameters, associated with the adoption of healthy habits and continuous professional monitoring, constitutes an essential element for the proper management of diabetes mellitus and for improving the quality of life of patients.
Downloads
References
AMERICAN DIABETES ASSOCIATION. Standards of medical care in diabetes—2023. Diabetes Care, Arlington, v. 46, n. 1, p. S1–S291, 2023. DOI: https://doi.org/10.2337/dc23-SINT. Acesso em: 12 jan. 2026.
ANTWI-BAFFOUR, S. et al. Evaluation of glycated hemoglobin and fasting plasma glucose as markers for glycemic control among diabetic patients. BMC Endocrine Disorders, London, v. 23, n. 1, p. 1–9, 2023. DOI: https://doi.org/10.1186/s12902-023-01310-0. Acesso em: 28 jan. 2026.
BECK, R. W. et al. Estimating glycemia from HbA1c and continuous glucose monitoring: analysis of accuracy and implications. Diabetes Care, Arlington, v. 47, n. 3, p. 460–467, 2024. DOI: https://doi.org/10.2337/dc23-1460. Acesso em: 31 jan. 2026.
COLBERG, S. R. et al. Physical activity and glycemic control in type 2 diabetes: a systematic review and meta-analysis. Diabetes Research and Clinical Practice, Amsterdam, v. 210, p. 111012, 2025. DOI: https://doi.org/10.1016/j.diabres.2025.111012. Acesso em: 20 fev. 2026.
HOLT, R. I. G.; DEVRIES, J. H.; HESS-FISCHL, A. Glycemic targets in diabetes management. The Lancet Diabetes & Endocrinology, London, v. 9, n. 11, p. 739–752, 2021. DOI: https://doi.org/10.1016/S2213-8587(21)00230-7. Acesso em: 18 fev. 2026.
KAIAFA, G. et al. Is HbA1c an ideal biomarker of well-controlled diabetes? Postgraduate Medical Journal, Oxford, v. 97, n. 1148, p. 380–383, 2021. DOI: https://doi.org/10.1136/postgradmedj-2020-138756. Acesso em: 09 fev. 2026.
KHUNTI, K. et al. Glycaemic control and cardiovascular outcomes in people with type 2 diabetes: population-based cohort study. BMJ Open, London, v. 11, n. 9, p. e048892, 2021. DOI: https://doi.org/10.1136/bmjopen-2021-048892. Acesso em: 02 mar. 2026.
LIU, Y. et al. Glycemic variability evaluated by HbA1c and fasting plasma glucose in adults with type 2 diabetes. Frontiers in Endocrinology, Lausanne, v. 15, p. 1323571, 2024. DOI: https://doi.org/10.3389/fendo.2024.1323571. Acesso em: 14 jan. 2026.
MA, H. et al. Divergent impacts of glycemic control on mortality and complications in patients with early-versus late-onset type 2 diabetes: a retrospective cohort study. PLOS ONE, San Francisco, v. 20, n. 5, p. e0322886, 2025. DOI: https://doi.org/10.1371/journal.pone.0322886. Acesso em: 22 fev. 2026.
SACKS, D. B. et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clinical Chemistry, Washington, v. 67, n. 1, p. 1–24, 2021. DOI: https://doi.org/10.1093/clinchem/hvaa268. Acesso em: 03 mar. 2026.
SAEEDI, P. et al. Global and regional diabetes prevalence estimates and projections for 2045. Diabetes Research and Clinical Practice, Amsterdam, v. 183, p. 109119, 2022. DOI: https://doi.org/10.1016/j.diabres.2021.109119. Acesso em: 24 jan. 2026.
SILVA, S. A. et al. Fatores associados ao controle glicêmico de pessoas com diabetes mellitus na atenção primária à saúde. Ciência & Saúde Coletiva, Rio de Janeiro, v. 26, n. 5, p. 1763–1772, 2021. Disponível em: https://www.scielo.br/j/csc. Acesso em: 17 jan. 2026.
STOPA, S. R. et al. Conhecimento do diagnóstico, tratamento e controle do diabetes mellitus na população brasileira. Revista de Saúde Pública, São Paulo, v. 57, p. 75, 2023. DOI: https://doi.org/10.11606/s1518-8787.2023057004810. Acesso em: 05 fev. 2026.
TANG, X. F. et al. Implications of baseline glycemic control by plasma glycated hemoglobin on long-term outcomes in coronary heart disease patients with type 2 diabetes. Heliyon, Amsterdam, v. 10, n. 3, p. e23456, 2024. DOI: https://doi.org/10.1016/j.heliyon.2024.e23456. Acesso em: 26 fev. 2026.
ZHANG, Y. et al. Glycemic control assessment and targets in type 2 diabetes: current perspectives. Diabetes Research and Clinical Practice, Amsterdam, v. 209, p. 110998, 2025. DOI: https://doi.org/10.1016/j.diabres.2025.110998. Acesso em: 11 mar. 2026.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
